Daniel Juneau

Daniel Juneau

Auto-generated profile, based on publicly available information

Daniel Juneau

Department of Medical Imaging, Centre Hospitalier de l’Université de Montréal, Montreal, Canada

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2022 in Seminars in Nuclear Medicine
Verified
Journal Article
Closed access
MLMarc-André Léger
Marc-André Léger
BRBertrand Routy
Bertrand Routy
DJDaniel Juneau
Daniel Juneau

1 December 2019 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
JWJeroen Walpot
Jeroen Walpot
DJDaniel Juneau
Daniel Juneau
SMSamia Massalha
Samia Massalha
GDGirish Dwivedi
Girish Dwivedi
FRFrank J. Rybicki
Frank J. Rybicki
JIJoão R. Inácio
João R. Inácio
Normal sex- and age-specific reference ranges for left ventricular mid-diastolic wall thickness (LV-MDWT) at prospective electrocardiographically triggered mid-diastolic CT angiography were provide... PurposeTo generate normal reference values for left ventricular mid-diastolic wall thickness (LV-MDWT) measured by using CT angiography.Materials and MethodsLV-MDWT was measured in 2383 consecutive...

31 October 2020 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
LCLena Cvetkovic
Lena Cvetkovic
CRClaudine Régis
Claudine Régis
CRCorentin Richard
Corentin Richard
LDLisa Derosa
Lisa Derosa
ALAntoine Leblond
Antoine Leblond
DJDaniel Juneau
Daniel Juneau
Background Immune checkpoint inhibitors (ICI) represent the backbone treatment for advanced non-small cell lung cancer (NSCLC). Emerging data suggest that increased gut microbiome diversity is associated with favorable response to ICI and that antibiotic-induced dysbiosis is associated with deleterious outcomes. 18F-FDG physiologic colonic uptake on PET/CT increases following treatment with antibiotics (ATB) and could act as a surrogate marker for microbiome composition and predict prognosis. The aim of this study was to determine if 18F-FDG physiologic colonic uptake prior to ICI initiation correlates with gut microbiome profiling and clinical outcomes in patients with advanced NSCLC. Methods Seventy-one patients with advanced NSCLC who underwent a PET/CT prior to ICI were identified. Blinded colonic contouring was performed for each colon segment and patients were stratified according to the median of the average colon SUVmax as well as for each segment in low vs. high SUVmax groups. Response rate, progression-free survival (PFS), and overall survival (OS) were compared in the low vs. high SUVmax groups. Gut microbiome composition was analyzed for 23 patients using metagenomics sequencing. Results The high colon SUVmax group had a higher proportion of non-responders (p = 0.033) and significantly shorter PFS (4.1 vs. 11.3 months, HR 1.94, 95% CI 1.11–3.41, p = 0.005). High caecum SUVmax correlated with numerically shorter OS (10.8 vs. 27.6 months, HR 1.85, 95% CI 0.97–3.53, p = 0.058). Metagenomics sequencing revealed distinctive microbiome populations in each group. Patients with low caecum SUVmax had higher microbiome diversity (p = 0.046) and were enriched with Bifidobacteriaceae, Lachnospiraceae, and Bacteroidaceae. Conclusions Lower colon physiologic 18F-FDG uptake on PET/CT prior to ICI initiation was associated with better clinical outcomes and higher gut microbiome diversity in patients with advanced NSCLC. Here, we propose that 18F-FDG physiologic colonic uptake on PET/CT could serve as a potential novel marker of gut microbiome composition and may predict clinical outcomes in this population.

3 January 2021 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
DJDaniel Juneau
Daniel Juneau
KWKai Yi Wu
Kai Yi Wu
NKNicole Kaps
Nicole Kaps
JYJason Yao
Jason Yao
JRJennifer M. Renaud
Jennifer M. Renaud
RDRobert A. Dekemp
Robert A. Dekemp

1 January 2021 in European Journal of Radiology Open
Verified
Journal Article
Open access
MSManel Sadouni
Manel Sadouni
IBIrina Boldeanu
Irina Boldeanu
MDMadeleine Durand
Madeleine Durand
DJDaniel Juneau
Daniel Juneau
SBSimon Blais
Simon Blais
CCCarl Chartrand-Lefebvre
Carl Chartrand-Lefebvre
To assess the reproducibility of different epicardial fat measurement and their association with other adiposity measurements in HIV-infected and non-HIV-infected patients. In this cross-sectional study, 167 HIV-infected and 58 non-HIV-infected consecutive participants (200 males; mean age 56 years) with low/intermediate cardiovascular risk were recruited between 2012 and 2017 from a large prospective cohort and underwent non-contrast cardiac CT. Two independent observers measured epicardial fat volume, area and thickness in all participants. For intra-observer agreement, one observer did a second assessment in a subset of 40 patients. Agreement was assessed with the intraclass correlation coefficient (ICC). Pearson's correlation was estimated to assess the association between epicardial fat, body-mass index (BMI) and dual-energy x-ray absorptiometry (DEXA) derived percentage of body fat. Inter-observer agreement was excellent for epicardial fat volume (ICC 0.75) and area (ICC 0.95) and good for epicardial fat thickness (ICC near the left anterior descending artery (LAD) 0.64, ICC near right coronary artery (RCA) 0.64). Intra-observer agreement was excellent for epicardial fat volume (ICC 0.97), area (ICC 0.99), thickness at LAD (ICC 0.71) and good for epicardial fat thickness at RCA (ICC 0.68). Epicardial fat volume had a better correlation to total body fat (r = 0.28, p < 0.001) and trunk fat (r = 0.37, p < 0.001), in comparison to other epicardial fat indices. Assessment of epicardial fat volume is highly reproducible in both HIV-infected and non-HIV-infected patients and shows a superior correlation with DEXA-based body and trunk fat measurements. Epicardial fat volume should be considered over other CT assessment methods when quantifying epicardial fat in HIV patients.

1 July 2020 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
DJDaniel Juneau
Daniel Juneau
PNPablo B. Nery
Pablo B. Nery
EPElena Pena
Elena Pena
JIJoão R. Inácio
João R. Inácio
RBRob S. B. Beanlands
Rob S. B. Beanlands
DBDavid Birnie
David Birnie